Report #2877794

Received Dec 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NJ
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (RECOMBIVAX HB)	MERCK & CO. INC.	UNK	—	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

Adult patient who experienced a one-month delay of vaccination with the third dose of RECOMBIVAXHB (reason unspecified).; No symptoms reported. No adverse event; This spontaneous report was received from a Nurse and refers to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. It was reported that on 02-Oct-2025, the patient was scheduled to receive the third dose of hepatitis b vaccine (recombinant) suspension for injection (RECOMBIVAX HB) as prophylaxis; however, she was expecting to receive the third dose in series on 07-Nov-2025 (inappropriate schedule of product administration). No symptoms reported. No adverse event (No adverse event).